66 participants
Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-05-08
- Start Date:
- 2003-12-31
- Completion:
- 2014-12-31
Conditions
- Chronic Lymphocytic Leukemia
Interventions
- DRUG